Authors: Twelves, C Boyer, M Findlay, M Cassidy, J Weitzel, C Baker, C Osterwalder, B Jamieson, C Hieke, K

Citation: C. Twelves et al., Capecitabine (Xeloda (TM)) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients withadvanced colorectal carcinoma, EUR J CANC, 37(5), 2001, pp. 597-604

Authors: Van Cutsem, E Twelves, C Cassidy, J Allman, D Bajetta, E Boyer, M Bugat, R Findlay, M Frings, S Jahn, M McKendrick, J Osterwalder, B Perez-Manga, G Rosso, R Rougier, P Schmiegel, WH Seitz, JF Thompson, P Vieitez, JM Weitzel, C Harper, P

Citation: E. Van Cutsem et al., Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study, J CL ONCOL, 19(21), 2001, pp. 4097-4106

Authors: Daumiller, I Schmid, P Kohn, E Kirchner, C Kamp, M Ebeling, KJ Pond, LL Weitzel, C

Citation: I. Daumiller et al., DC and RF characteristics of AlN/GaN doped channel heterostructure field effect transister, PHYS ST S-A, 176(1), 1999, pp. 179-181

Authors: Daumiller, I Schmid, P Kohn, E Kirchner, C Kamp, M Ebeling, KJ Pond, LL Weitzel, C

Citation: I. Daumiller et al., DC and RF characteristics of AlN/GaN doped channel heterostructure field effect transistor, ELECTR LETT, 35(18), 1999, pp. 1588-1590